Search Orphan Drug Designations and Approvals
-
Generic Name: | baricitinib |
---|---|
Date Designated: | 11/02/2017 |
Orphan Designation: | Treatment of pediatric systemic lupus erythematosus |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 05/06/2022 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Eli Lilly and Company Lilly Corporate Center Indianapolis, Indiana 46285 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-